Morepen Laboratories has informed that it enclosed press release with the titled, ‘Morepen Labs Q4 Net Profit Rises 69%; CDMO Program Moves into Commercial Execution; Board Proposes a Dividend of 10% to the shareholders for FY26’.
The above information is a part of company’s filings submitted to BSE.